Design, Synthesis, and Antimycobacterial Evaluation of Novel Tetrahydroisoquinoline Hydrazide Analogs

A series of novel 2‐substituted‐5,7‐dichloro‐1,2,3,4‐tetrahydroisoquinoline‐6‐carbohydrazide were designed, synthesized and structures were confirmed by analytical methods, viz., 1H‐NMR, 13C‐NMR and Mass spectrometry. Synthesized derivatives were evaluated for their anti‐mycobacterial activity against Mycobacterium tuberculosis (Mtb) H37Ra. Among all the evaluated compounds, 10A25 containing biphenyl moiety exhibited significant inhibition with IC50 4.7 μM. 10A19, with an electron‐withdrawing Iodo group in the ortho position of the phenyl exhibited significant anti‐tubercular activity with IC50 8.8 μM. IC50 values of the remaining compounds ranged from 9.2 to 73.6 μM. Molecular docking study of the significantly active compound 10A25 was performed to determine the putative binding position of the test ligand at the active site of the selected target proteins Mycobacterium tuberculosis enoyl reductase (InhA) PDB – 4TZK and peptide deformylase PDB – 3E3U. A suitable single crystal for one of the active compounds, 10A12, was generated and analysed to further confirm the structure of the compounds.

[1]  J. Cavalier,et al.  Design, synthesis and antibacterial activity against pathogenic mycobacteria of conjugated hydroxamic acids, hydrazides and O-alkyl/O-acyl protected hydroxamic derivatives. , 2022, Bioorganic & medicinal chemistry letters.

[2]  J. Mague,et al.  Nitrophenyl-Group-Containing Heterocycles. I. Synthesis, Characterization, Crystal Structure, Anticancer Activity, and Antioxidant Properties of Some New 5,6,7,8-Tetrahydroisoquinolines Bearing 3(4)-Nitrophenyl Group , 2022, ACS omega.

[3]  E. Harry,et al.  Synthesis and biological evaluation of tetrahydroisoquinoline-derived antibacterial compounds. , 2022, Bioorganic & medicinal chemistry.

[4]  Christopher B. Cooper,et al.  Synthesis and structure-activity relationships for a new class of tetrahydronaphthalene amide inhibitors of Mycobacterium tuberculosis , 2021, European journal of medicinal chemistry.

[5]  A. Ullah,et al.  Natural products based crown ethers: synthesis and their anticancer potential , 2021, Journal of Asian natural products research.

[6]  Shalini,et al.  Biological and Biochemical Evaluation of Isatin-Isoniazid Hybrids as Bactericidal Candidates against Mycobacterium tuberculosis , 2021, Antimicrobial agents and chemotherapy.

[7]  S. Chander,et al.  Medicinal chemistry perspectives of 1,2,3,4-tetrahydroisoquinoline analogs – biological activities and SAR studies , 2021, RSC advances.

[8]  P. Yablonskiy,et al.  Isonicotinoyl hydrazones of pyridoxine derivatives: synthesis and antimycobacterial activity , 2021, Medicinal Chemistry Research.

[9]  Christopher B. Cooper,et al.  Synthesis and structure-activity relationships for tetrahydroisoquinoline-based inhibitors of Mycobacterium tuberculosis , 2020, Bioorganic & medicinal chemistry.

[10]  A. Turjanski,et al.  New one-pot synthesis of anti-tuberculosis compounds inspired on isoniazid. , 2020, European journal of medicinal chemistry.

[11]  I. Barberis,et al.  HIV and tuberculosis: The paradox of dual illnesses and the challenges of their fighting in the history. , 2020, Tuberculosis.

[12]  L. Verschaeve,et al.  Synthesis and in vitro investigation of halogenated 1,3‐bis(4‐nitrophenyl)triazenide salts as antitubercular compounds , 2018, Chemical biology & drug design.

[13]  A. Scala,et al.  Synthesis of C3/C1-Substituted Tetrahydroisoquinolines , 2015, Molecules.

[14]  Richard A. Bunce,et al.  Recent Syntheses of 1,2,3,4-Tetrahydroquinolines, 2,3-Dihydro-4(1H)-quinolinones and 4(1H)-Quinolinones using Domino Reactions , 2013, Molecules.

[15]  G. Aithal,et al.  Hepatotoxicity Related to Anti-tuberculosis Drugs: Mechanisms and Management. , 2013, Journal of clinical and experimental hepatology.

[16]  A. Willis,et al.  Antimalarial alkaloids from a Bhutanese traditional medicinal plant Corydalis dubia. , 2012, Journal of ethnopharmacology.

[17]  A. Verma,et al.  Synthesis, antibacterial activity and QSAR studies of 1,2-disubstituted-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolines. , 2006, European journal of medicinal chemistry.

[18]  A. Clearfield,et al.  Synthesis of carbon-11 and fluorine-18 labeled N-acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives as new potential PET AMPA receptor ligands. , 2006, Bioorganic & medicinal chemistry letters.

[19]  Robin M. Williams,et al.  Chemistry and biology of the tetrahydroisoquinoline antitumor antibiotics. , 2002, Chemical reviews.

[20]  C. Dolea,et al.  World Health Organization , 1949, International Organization.